I did all the calculations one more time for

New Post Public Reply Private Reply Replies (4) Message Board
polkadot

I did all the calculations one more time for confirmation.

First thing first though where is this number 100mg/kg in mice before p21 expression noted because I can not find it. I do see studies where they did 200/mg/kg mice and measuring the amount of P21 expression @ 6hr and 16hr. At 6hr the expression was 3x that of controls and at 16hr it was 5x that of controls. Likely because of some form of cascading pathway so what affect this may have at 24hr, etc.. is not yet known to us and we would need to consider clearance and half-life of the drug.

If we do use the 100mg/kg in mice as the first expression of p21 in the studies then I can agree with an equivalent in human. My calculation is 308 mg/m/m so thats spot on. I think I would like to see where that 100 number came from because p21 expression may actually be at a much lower dose.

For DLT comparisons:

NOAEL in mice was 90mg/kg or 277.5mg/m/m in human

NOAEL in dog was 5mg/kg (although symptoms were mild) which is 26.43mg/m/m in humans

With a caveat on these because the doses were given 5x weekly (clearance and half-life issues here!!) and the goal for this kind of study is just to find out the toxicity thats it. So they pumped um full of drugs to find that out.

Also and what everyone seems to be missing is p21 is not the only indicator of efficacy. They say it a PROBABLE that p21 expression means p53 activation.

They could also be seeing tumor reduction which is tested verses baseline at 2mo,4mo,6mo.

They are also testing at least 5 tumor markers for reduction in serum markers verses baseline at 1mo,2mo,3mo,4mo,5mo,6mo.

What I never understood was this idea that they just happened to do p21 biomarkers early when it specifically states in the protocol that the patients would be tested verses baseline at 7hr and 24 hr after EACH dose. A facility such as this has immediate access to qpcr equipment and the department costs are likely around $200 per test with a couple hour turn around if it is sent to another part of the facility but I would bet a couple pennies that there is a machine within five minute walk of their unit. There is not a cancer research facility in this country without one.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 75

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
Africa Tech Awards Put Infrastructure Back in Focus

Updated Category News Views 97

Twelve trophies in Cape Town tell a more useful story than most glossy technology forecasts ever manage to. The Africa Tech Festival Awards 2026, announced on November 19 during the event's 29th annual gathering, cut across connectivity, telecoms, AI, cybersecurity, data centres, cloud, fintech, startups and enterprise transformation. That breadth matters. Africa's...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 48

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 93

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 148

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 78

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 53

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
FLX Opens a New Door to Pre-IPO Deal Flow for Advisors

Updated Category News Views 172

Private-market chatter has been leaking past the velvet rope for years, and advisors are sick of learning about it after a client already has a pitch deck in hand. FLX Networks is responding to that irritation by letting its eligible advisor and wealth-management members review select pre-IPO opportunities shared by other members. Announced November 19, 2026, the move is...

Continue Reading
Humana's Medicare Audit Shock Puts Disclosure in Focus

Updated Category News Views 134

Medicare Advantage just reminded Wall Street that reimbursement plumbing can wreck a perfectly calm-looking stock in a hurry. Humana shareholders watched that lesson land hard on November 18, when reports surfaced of a proposed federal CRUSH rule aimed at fraud, waste, and improper payments in the program. The reported response in NYSE:HUM was ugly: an early account put...

Continue Reading
Sailun’s COP31 Pitch Rests on Tire Tech and Hard Proof

Updated Category News Views 91

Antalya Put Tire Chemistry on a Very Public Stage Rubber tires rarely get a starring role at a climate summit, which is exactly why Sailun Group’s appearance at COP31 deserves a closer look. From November 9 through 20 in Antalya, Türkiye, Chairwoman Yanhua Liu used the United Nations climate gathering to lay out the company’s case: better tire technology can cut...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Trends: The Effects of Inflation on Stock Futures

Updated Category News Views 87

Understanding Stock Market Movements Amid Inflation The stock market is always changing, and the way inflation data interacts with labor statistics often shapes its future direction. Recently, U.S. stock futures saw a slight uptick as investors digested fresh figures, weighing how these will influence upcoming decisions regarding interest rate cuts. Current Market...

Continue Reading
SMBC Nikko America Achieves Primary Dealer Status with Fed

Updated Category News Views 557

SMBC Nikko America Achieves Primary Dealer Designation SMBC Nikko Securities America, Inc., commonly referred to as SMBC Nikko America, has recently been honored with the designation of primary dealer by the Federal Reserve Bank of New York. This prestigious status is not only a recognition of the firm’s robust capabilities but also signals significant opportunities for...

Continue Reading
USD and Global Currency Trends Amid Upcoming Economic Events

Updated Category News Views 272

Currency Market Insights for the Upcoming Week As economic indicators and central bank policies loom large, the focus shifts to the financial markets where currencies react to evolving data. The US dollar has shown resilience recently, making a notable comeback. This rebound is attributed to a combination of safe haven flows and exceptionally positive data releases. Fed...

Continue Reading
Transforming $100 into Wealth: American Tower's Success Story

Updated Category News Views 152

The Wealth Generated by American Tower's Growth American Tower (NYSE: AMT) has exhibited exceptional performance over the past two decades, consistently outshining the market with a remarkable annual return of 10.05%. As of now, this powerhouse company boasts a market capitalization of approximately $83 billion, signaling its robust position in the telecommunications...

Continue Reading
Calcea: The Future of Calcium with Plant-Based Solutions

Updated Category News Views 258

Revolutionizing Calcium Supplements with Calcea Calcium is recognized as the most abundant mineral in the human body, yet many of the supplements available today are derived from ground-up rocks – materials that aren't aligned with the nutritional needs of the human body. With consumers increasingly prioritizing cleaner and more effective supplements, the calcium market...

Continue Reading